Oxazoline pseudodimers, pharmaceutical compositions and the use thereof
US10858326B2 · kind B2 · utility
0Cited by
15References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 4, 2017 |
| Grant date | Dec 8, 2020 |
| Priority date | — |
| Expiry date | May 4, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/06
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present disclosure is directed to oxazoline mono- and hetero-pseudodimer compounds, such as compounds of Formula (I) or pharmaceutically acceptable salts or solvates thereof: These compounds are useful for treating pain. The present disclosure also relates to pharmaceutical compositions comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of a compound of Formula (I) or (II) or a pharmaceutically acceptable salt or solvate thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.